Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-001848

Options or other derivatives

  • PRESIDENT AND CEO acquired 1,702,396 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Aggarwal Sumit PRESIDENT AND CEO 2021-04-01 Grant or award · Restricted Stock Units +223,304 223,304 D
Aggarwal Sumit PRESIDENT AND CEO 2021-04-01 Grant or award · Restricted Stock Units +55,854 279,158 D
Aggarwal Sumit PRESIDENT AND CEO 2021-04-01 Grant or award · Stock Options (Right to Buy) +1,423,238 1,423,238 D
Loading xslF345X03/form4-04022021_050420.xml…